{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:36:28Z","timestamp":1790314588722,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T00:00:00Z","timestamp":1321920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00432-011-1094-x","type":"journal-article","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T11:54:45Z","timestamp":1321876485000},"page":"261-267","source":"Crossref","is-referenced-by-count":9,"title":["Nodal status\u2014its impact on prognosis in advanced ovarian cancer"],"prefix":"10.1007","volume":"138","author":[{"given":"C.","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Staebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rothmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gardanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Grischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wallwiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. F.","family":"Solomayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,22]]},"reference":[{"issue":"5","key":"1094_CR1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1447-0756.2010.01274.x","volume":"36","author":"A Abe","year":"2010","unstructured":"Abe A, Furumoto H, Irahara M, Ino H, Kamada M, Naka O, Sasaki M, Kagawa T, Okitsu O, Kushiki N (2010) The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer. J Obstet Gynaecol Res 36(5):1023\u20131030","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"1094_CR2","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.ajog.2006.06.068","volume":"195","author":"GD Aletti","year":"2006","unstructured":"Aletti GD, Dowdy S et al (2006) Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 195(6):1862\u20131868","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1094_CR4","first-page":"289","volume":"30","author":"G Balbi","year":"2009","unstructured":"Balbi G, Manganaro MA, Monteverde A, Landino I, Franzese C, Gioia F (2009) Ovarian cancer: lymphnode metastases. Eur J Gynaecol Oncol 30(3):289\u2013291","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"1094_CR5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS et al (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20(5):1248\u20131259","journal-title":"J Clin Oncol"},{"issue":"3","key":"1094_CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1006\/gyno.1997.4633","volume":"65","author":"F Carnino","year":"1997","unstructured":"Carnino F, Fuda G et al (1997) Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 65(3):467\u2013472","journal-title":"Gynecol Oncol"},{"issue":"12","key":"1094_CR7","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.bjc.6603803","volume":"96","author":"JK Chan","year":"2007","unstructured":"Chan JK, Urban R et al (2007) The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer 96(12):1817\u20131822","journal-title":"Br J Cancer"},{"issue":"34","key":"1094_CR8","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1200\/JCO.2005.02.1287","volume":"23","author":"SC Crawford","year":"2005","unstructured":"Crawford SC, Vasey PA et al (2005) Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial. J Clin Oncol 23(34):8802\u20138811","journal-title":"J Clin Oncol"},{"issue":"3","key":"1094_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/gyno.1996.0249","volume":"62","author":"F Re di","year":"1996","unstructured":"di Re F, Baiocchi G, Fontanelli R, Grosso G, Cobellis L, Raspagliesi F, di Re E (1996) Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol Oncol 62(3):5\u2013360","journal-title":"Gynecol Oncol"},{"key":"1094_CR10","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"15","author":"A Du Bois","year":"2009","unstructured":"Du Bois A et al (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials. Cancer 15:1234\u20131244","journal-title":"Cancer"},{"issue":"2","key":"1094_CR11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","volume":"69","author":"SM Eisenkop","year":"1998","unstructured":"Eisenkop SM, Friedman RL et al (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69(2):103\u2013108","journal-title":"Gynecol Oncol"},{"issue":"12","key":"1094_CR12","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, Bois A et al (2006) Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol 13(12):1702\u20131710","journal-title":"Ann Surg Oncol"},{"key":"1094_CR13","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1525-1438.2007.00931.x","volume":"17","author":"P Harter","year":"2007","unstructured":"Harter P, Gnauert K et al (2007) Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer 17:1238\u20131244","journal-title":"Int J Gynecol Cancer"},{"key":"1094_CR14","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1245\/s10434-009-0357-0","volume":"16","author":"P Harter","year":"2009","unstructured":"Harter P, Hahmann M, Lueck HJ, Poelcher M, Wimberger P, Ortmann O, Canzler U, Richter B, Wagner U, Hasenburg A, Burges A, Loibl S, Meier W, Huober J, Fink D, Schroeder W, Muenstedt K, Schmalfeldt B, Emons G, du Bois A (2009) Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Ann Surg Oncol 16:1324\u20131330","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1094_CR15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","volume":"70","author":"WJ Hoskins","year":"1994","unstructured":"Hoskins WJ, McGuir WP et al (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 70(4):974\u2013979","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1094_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s007950300002","volume":"36","author":"T Kaku","year":"2003","unstructured":"Kaku T, Ogawa S et al (2003) Histological classification of ovarian cancer. Med Electron Microsc 36(1):9\u201317","journal-title":"Med Electron Microsc"},{"issue":"4","key":"1094_CR17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/IGC.0b013e3181d6de1d","volume":"20","author":"HS Kim","year":"2010","unstructured":"Kim HS et al (2010) Systematic lymphadenectomy for survival in epithelial ovarian cancer. Int J Gynecol Cancer 20(4):520\u2013528","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"1094_CR18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00004347-200010000-00009","volume":"19","author":"D Mayr","year":"2000","unstructured":"Mayr D, Diebold J (2000) Grading of ovarian carcinomas. Int J Gynecol Pathol 19(4):348\u2013353","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"1094_CR19","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R","volume":"83","author":"T Onda","year":"1998","unstructured":"Onda T, Yoshikawa H et al (1998) Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to stage I\/II patients and superior survival to other stage III patients. Cancer 83(8):1555\u20131560","journal-title":"Cancer"},{"issue":"8","key":"1094_CR20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A et al (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97(8):560\u2013566","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1094_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004320000153","volume":"127","author":"IB Runnebaum","year":"2001","unstructured":"Runnebaum IB, Stickeler E (2001) Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 127(2):73\u201379","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"1094_CR22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1525-1438.2002.01171.x","volume":"12","author":"Saygili","year":"2002","unstructured":"Saygili (2002) The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma. Int J Gynecol Cancer 12(5):438\u2013442","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1094_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1525-1438.1997.00418.x","volume":"7","author":"C Scarabelli","year":"1997","unstructured":"Scarabelli C, Gallo A et al (1997) Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease. Int J Gynecol Cancer 7(1):18\u201326","journal-title":"Int J Gynecol Cancer"},{"key":"1094_CR24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-008-0306-9","volume":"17","author":"E Stickeler","year":"2009","unstructured":"Stickeler E, Klar M, Watermann D, Geibel A, F\u00f6ldi M, Hasenburg A, Gitsch G (2009) Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2\/neu positive metastatic breast cancer: a multicenter phase II trial. Breast Cancer Res Treat 17:591\u2013598","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1094_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2005.06.051","volume":"99","author":"N Takeshima","year":"2005","unstructured":"Takeshima N et al (2005) Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol 99(2):427\u2013431","journal-title":"Gynecol Oncol"},{"issue":"3 Pt 2","key":"1094_CR26","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1006\/gyno.1994.1334","volume":"55","author":"AS Whittemore","year":"1994","unstructured":"Whittemore AS (1994) Characteristics relating to ovarian cancer risk: implications for prevention and detection. Gynecol Oncol 55(3 Pt 2):S15\u2013S19","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1094_CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2007.02.026","volume":"106","author":"P Wimberger","year":"2007","unstructured":"Wimberger P, Lehmann N, Kimmig R, Burges A, Meier W, Du Bois A, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (2007) Prognostic factors for complete debulking in advanced ovarian cancer, its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol 106(1):69\u201374","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1094-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-011-1094-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1094-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:40:05Z","timestamp":1559083205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-1094-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,22]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-1094-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,22]]}}}